ask="8.14"
ask_size="5000"
average_daily_volume="38502"
bid="4.31"
bid_size="1000"
book_value="1.28"
change="+0.08"
change_from_200_day_moving_average="1.04"
change_from_50_day_moving_average="0.68"
change_from_52_week_high="-2.72"
change_From_52_week_low="2.22"
change_in_percent="+1.63%"
close="5.00"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.38"
ebitda="-15.34M"
eps_estimate_current_year="-1.39"
eps_estimate_next_quarter="-0.30"
eps_estimate_next_year="-1.17"
ex_dividend_date="N/A"
float_shares="6708000"
high="5.24"
high_52_weeks="7.72"
last_trade_date="3/3/2017"
last_trade_price="5.00"
last_trade_size="150"
last_trade_time="4:00pm"
low="4.81"
low_52_weeks="2.78"
market_capitalization="60.75M"
moving_average_200_day="3.96"
moving_average_50_day="4.32"
name="Galmed Pharmaceuticals Ltd."
notes="N/A"
one_year_target_price="13.40"
open="5.03"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+26.39%"
percent_change_from_50_day_moving_average="+15.76%"
percent_change_from_52_week_high="-35.23%"
percent_change_from_52_week_low="+79.86%"
previous_close="4.92"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.85"
price_per_sales="309.71"
revenue="193000.00"
shares_outstanding="12149000"
short_ratio="3.92"
stock_exchange="NCM"
symbol="GLMD"
volume="29319"
weeks_range_52="2.78 - 7.72"
